Spinal cord injury (SCI) is an injury to the spinal cord that leads to varying degrees of motor and/or sensory deficits and paralysis. Chronic pain of both neuropathic and nociceptive type is 
INTRODUCTION
A spinal cord injury (SCI) is an injury to the spinal cord that leads to varying degrees of motor and/or sensory deficits and paralysis [1] . Although injury of the cauda equina is included, the definition excludes isolated injuries to other nerve roots [2] . The condition may lead to lifelong loss of function, autonomic disturbances and reduced quality of life, as well as increased morbidity and mortality.
Pain is common in patients with SCI [3] [4] [5] . The pain may be of nociceptive or neuropathic type or a combination of the two. Neuropathic pain following SCI is caused by damage to or dysfunction of the nervous system, while nociceptive pain is caused by damage to nonneural tissue either musculoskeletal due to bone, joint, muscle trauma or inflammation, mechanical instability or muscle spasm. Pain of visceral origin may develop for instance due to renal calculus, bowel, sphincter dysfunction, headache related to autonomic dysreflexia and secondary overuse syndromes [6, 7] .
The pain may be localized above, at or below the level of the SCI and may persist for many years after the acute injury [8] [9] [10] . Pain may occur immediately after the acute injury or develop and increase in intensity a long time after the injury [8, 11] . Neuropathic pain is found to contribute to reduce quality of life in patients with SCI [8, 11] .
Current review is based on search in PubMed 
EPIDEMIOLOGY OF SCI AND NEUROPATHIC PAIN FOLLOWING SCI
There are large variations in incidence, prevalence, gender distribution, mechanisms, level and completeness of SCI worldwide [12] [13] [14] [15] [16] [17] [18] [19] . The global incidence of traumatic SCI is estimated to be 23 cases per 1,000,000 persons in 2007 and is dependent on regional results [20] . The reported annual incidence ranges from 2.3 per million in one Canadian study to 83 per million in a study from Alaska [18] [19] [20] [21] .
Differences in definition, inclusion criteria, classification and procedures for identification of patients as well as geographical and cultural issues may contribute to a vast range of annual incidence reported in the studies [16, 21] .
Information about prevalence of traumatic SCI is scarce [18] . The lowest reported prevalence is from India, 236 per million population [22] , and the highest from the USA, 4187 per million population [23] . The incidence and prevalence of non-traumatic SCI are very limited and the results are uncertain.
Neuropathic pain is a common complication following SCI. The prevalence of pain in SCI is reported between 18% and 96%, the variation may be explained by differences in selection of study populations [4, 24] . Pain is usually described as present in 60-69% of the SCI population [5] . Most individuals with chronic pain and SCI report more than one pain problem [24] . Prevalence of chronic pain in individuals with SCI is reported to be 11-94%, and severe, disabling pain in 18-63% [24] .
Clinical Characteristics of Neuropathic
Pain Following SCI Neuropathic pain above the level of injury is often caused by concomitant compressive radiculopathies or sometimes by complex regional pain syndromes. Neuropathic pain at the level of injury is caused by nerve-root compression development of complications such as syringomyelia or SCI itself, while neuropathic pain below the level of injury is caused by spinal cord trauma or disease [2] .
A recent prospective study followed 90 patients with traumatic SCI 1, 6 and 12 months after the injury [7] . Eighty-eight patients completed the 12-month follow-up.
Approximately, 80% of the patients reported any type of pain at all periods evaluated.
Neuropathic pain related to SCI increased over time, and musculoskeletal pain decreased slightly, with both being present in 59% of patients at 12 months; other neuropathic pain not related to SCI and visceral pain were present in 1-3%. Early sensory changes (particularly cold-evoked dysesthesia) indicated development of neuropathic pain below the level of injury later [7] . 
CLASSIFICATION OF NEUROPATHIC PAIN IN SCI
Neuropathic pain is defined as proposed by the International Association for the Study of Pain (IASP) as ''pain initiated or caused by a primary lesion or dysfunction of the nervous system'' [25] . Neuropathic pain is divided into peripheral and central pain [25] [26] [27] . Pain after SCI is classified according to type, localization and level of injury [8] .
A typical feature of central neuropathic pain following SCI is its localization below the level of the injury combined with sensory phenomena such as allodynia or hyperalgesia in the painful area [8, 9] . Central neuropathic pain may develop months or years after the injury [8] [9] [10] . Development of neuropathic pain a long time after SCI may be a sign of posttraumatic syringomyelia [8] .
Neuropathic pain above the level of injury is usually not due to the SCI itself. Patients who use a manual wheelchair may experience carpal tunnel syndrome and peripheral neuropathic pain as a result and shoulder pain due to muscular overuse [28, 29] . Peripheral neuropathic pain at injury level can be due to concomitant injury to the nerve root.
Both nociceptive and neuropathic pain may vary in intensity and may be dependent on daily activities as well as being affected by the individual's psychosocial environment [30] .
PATHOPHYSIOLOGY
Numerous and complex changes in the nervous system will take place after development of pain following SCI.
A number of molecular changes will occur after SCI including changes in sodium ion- 
CLINICAL EXAMINATION
A thorough examination is important to identify any possible somatic cause of the pain other than SCI and to classify the type of pain to optimize therapy. The localization, duration, intensity and characteristics of pain are useful information when assessing the pain [8, 32] .
The clinical examination must include a neurological status with a mapping of sensory phenomena in the painful area, indicating the presence of neuropathic pain [32] . It is important to collect data regarding previous surgical and medical treatment [8] . Information will help to find possible underlying causes, classify pain type and relate localization to previous SCI correctly as well as choose appropriate modalities of further management.
Pain intensity can be assessed using a visual analog scale (VAS) or numeric rating scales [8, 33] . Pain characteristics can be mapped using 
TREATMENT

Established Pharmacological Treatment
Neuropathic pain after SCI often emerges as a chronic condition and responds poorly to a single drug. However, monotherapy will help to identify effectiveness of a single drug.
Information about expected effect, the timeline of treatment and need for follow-up should be clearly explained to patients.
Freedom from pain is often not realistic, instead modulation of the neuropathic pain may be a more achievable goal.
Pharmacological treatment of neuropathic pain following SCI is in general long-lasting process and both expected effect and side effects should be considered before the start and during follow-up. Table 1 gives an overview of randomized clinical studies performed on patients with neuropathic pain following SCI. [ Intravenously given morphine did not show effect in a crossover study in patients with neuropathic pain due to different conditions including SCI [59] . Clonidine together with morphine given intrathecally has been used in two studies including in total of 23 participants [60, 61] . Both studies concluded favorable effect of treatment [60, 61] .
The use of Oxycodone, an oral opioid has demonstrated additional improvement of pain in patients with SCI and neuropathic pain pretreated with antiepileptic drugs [62] . Use of opioids alone or with other medications may be an option. However, side effects such as constipation, nausea and cognitive deprivation along with the risk of drug abuse may complicate a long-term use.
Other Anti-Analgesics Intravenous lidocaine has shown effect on the patients with SCI and neuropathic pain in a limited study [63] . A per oral analog to lidocaine, mexiletine was, however, not effective in another 4-week placebo-controlled randomized study where only 11 patients completed the study [64] .
Ketamine, a NMDA receptor antagonist, was compared with other drugs in three studies [63, 65, 66] . Intravenous ketamine together with oral gabapentin showed better effect than gabapentin and placebo immediately after administration [65] . However, the effect was not present 2 weeks after treatment. Another study compared the effect of ketamine (in dose 0.4 mg/kg) with lidocaine (2.5 mg/kg) and placebo. Ketamine, but not lidocaine, showed significant effect [67] . The third study investigated the effect of ketamine together with l-receptor agonist alfentanil compared with placebo [66] . This study showed significant effect in patients with SCI and neuropathic pain with dysesthesia.
Intravenously administered lidocaine in dosage 5 mg/kg has also shown effect [63] . However, daily intravenous administration will limit the use of these medications on patients with long-lasting pain.
Cannabis-based medications have been studied both in patients with neuropathic pain and also in patients suffering from spasticity related pain in particular. A pilot study on Dronabinol, oral cannabinoid given 5-20 mg daily to patients with SCI and neuropathic pain did not show better effect than placebo [68] .
Two studies using cannabis spray on a mixed cohort including patients with SCI demonstrated significant effect on neuropathic pain [69, 70] . The studies are so far too limited and efficacy of cannabinoids and opioids is questionable.
Treatment of neuropathic pain after SCI may include use of topical agents [71] . Topical use of 0.025% capsaicin ointments was studied in a retrospective study including only eight patients, proved effective on neuropathic pain [72] . Topical use of lidocaine or high doses of capsaicin (8%) has not been studied on patients with SCI. These drugs have, however, shown effect on the other types of neuropathic pains [56, 73] . Another new approach for treatment of well-localized neuropathic pain is intradermal use of botulinum toxin A injections [73] . This treatment has not been tried on SCI-related neuropathic pain, but it proved effective in the cases with chronic neuropathic pain after surgery or trauma [74] . The treatment should be studied further on patients with SCI-related neuropathic pain in future.
A recent systematic review compared all available pharmacologic therapies for neuropathic pain following SCI and concluded that available studies are small and cause insufficient data for quantitative comparisons [75] .
Other Options of Treatment of Neuropathic Pain Following SCI
Two studies examined the effect of transcutaneous electrical nerve stimulation (TENS) on neuropathic pain following SCI [76, 77] . Low-frequency TENS demonstrated a favorable effect on pain [77] . Transcranial electric stimulation either alone or together with visual illusions was studied in several studies [78] [79] [80] [81] . Favorable effect was demonstrated in all studies. One observational study exploring the effect of visual illusions demonstrated significant reduction of pain as measured by VAS [82] . Transcranial magnetic stimulation did not however show significant effect in two studies on SCI patients [83, 84] . One study, exploring effect of deep brain stimulation did not demonstrate effect of such procedure [85] . Two studies, one of them a mixed cohort, have shown partial effect of DREZotomy (Dorsal Root Entry Zone-a surgical treatment) on neuropathic pain [86, 87] .
One observational study investigated the effect of acupuncture or massage on neuropathic pain following SCI [88] . Comparing pain before and after treatment, reduction of pain was reported with both acupuncture and massage. Osteopathic manipulation did not however show any effect in SCI patients with neuropathic pain [89] .
Management of Both Neuropathic Pain and Nociceptive Pain
Both nociceptive and neuropathic pain may occur simultaneously in patients with SCI.
Given this, management of both types of pain should be addressed. The effect of single pain medication or combinations against mixed types of pain after SCI has not been systematically studied. Non-steroidal antiinflammatory drugs and opioid medication is widely clinically used [90] . Acupuncture, manual therapy, hypnosis and biofeedback have demonstrated effect on nociceptive pain and should be considered as possible options of non-pharmacological treatment in the cases with mixed pain [91] [92] [93] . Physiotherapy can alleviate nociceptive pain and should be considered, particularly if muscular shoulder pain is present [94] [95] [96] . 
